93 related articles for article (PubMed ID: 17359484)
41. Sphingosine-1-phosphate: A bioactive lipid that confers high-density lipoprotein with vasculoprotection mediated by nitric oxide and prostacyclin.
Rodríguez C; González-Díez M; Badimon L; Martínez-González J
Thromb Haemost; 2009 Apr; 101(4):665-73. PubMed ID: 19350109
[TBL] [Abstract][Full Text] [Related]
42. Targeting sphingosine-1-phosphate signalling for cardioprotection.
Kennedy S; Kane KA; Pyne NJ; Pyne S
Curr Opin Pharmacol; 2009 Apr; 9(2):194-201. PubMed ID: 19070545
[TBL] [Abstract][Full Text] [Related]
43. [A new therapeutic approach for autoimmune diseases by the sphingosine 1-phosphate receptor modulator, fingolimod (FTY720)].
Chiba K
Nihon Rinsho Meneki Gakkai Kaishi; 2009 Apr; 32(2):92-101. PubMed ID: 19404007
[TBL] [Abstract][Full Text] [Related]
44. [New therapeutic approach for autoimmune diseases by the sphingosine 1-phosphate receptor modulator, fingolimod (FTY720)].
Chiba K
Yakugaku Zasshi; 2009 Jun; 129(6):655-65. PubMed ID: 19483408
[TBL] [Abstract][Full Text] [Related]
45. Sphingosine-1-phosphate signaling and the skin.
Herzinger T; Kleuser B; Schäfer-Korting M; Korting HC
Am J Clin Dermatol; 2007; 8(6):329-36. PubMed ID: 18039015
[TBL] [Abstract][Full Text] [Related]
46. Sphingosine 1-phosphate receptor modulators: a new class of immunosuppressants.
Yopp AC; Ledgerwood LG; Ochando JC; Bromberg JS
Clin Transplant; 2006; 20(6):788-95. PubMed ID: 17100731
[TBL] [Abstract][Full Text] [Related]
47. Targeting sphingosine-1-phosphate in hematologic malignancies.
Stevenson CE; Takabe K; Nagahashi M; Milstien S; Spiegel S
Anticancer Agents Med Chem; 2011 Nov; 11(9):794-8. PubMed ID: 21707492
[TBL] [Abstract][Full Text] [Related]
48. [Research progress of the selective sphingosine-1-phosphate receptor 1 agonists].
Tian YL; Jin J; Wang XJ
Yao Xue Xue Bao; 2012 Jan; 47(1):7-17. PubMed ID: 22493799
[TBL] [Abstract][Full Text] [Related]
49. FTY720 on the way from the base camp to the summit of the mountain: relevance for remyelination.
Kipp M; Amor S
Mult Scler; 2012 Mar; 18(3):258-63. PubMed ID: 22383435
[TBL] [Abstract][Full Text] [Related]
50. Regulation of macrophage function by sphingosine-1-phosphate.
Weigert A; Weis N; Brüne B
Immunobiology; 2009; 214(9-10):748-60. PubMed ID: 19625101
[TBL] [Abstract][Full Text] [Related]
51. Sphingosine 1-phosphate in coagulation and inflammation.
Obinata H; Hla T
Semin Immunopathol; 2012 Jan; 34(1):73-91. PubMed ID: 21805322
[TBL] [Abstract][Full Text] [Related]
52. "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets.
Takabe K; Paugh SW; Milstien S; Spiegel S
Pharmacol Rev; 2008 Jun; 60(2):181-95. PubMed ID: 18552276
[TBL] [Abstract][Full Text] [Related]
53. FTY720 (fingolimod) for relapsing multiple sclerosis.
Horga A; Montalban X
Expert Rev Neurother; 2008 May; 8(5):699-714. PubMed ID: 18457527
[TBL] [Abstract][Full Text] [Related]
54. Tipping the gatekeeper: S1P regulation of endothelial barrier function.
Rosen H; Sanna MG; Cahalan SM; Gonzalez-Cabrera PJ
Trends Immunol; 2007 Mar; 28(3):102-7. PubMed ID: 17276731
[TBL] [Abstract][Full Text] [Related]
55. Impact of sphingosine 1-phosphate modulation on immune outcomes.
Pinschewer DD; Brinkmann V; Merkler D
Neurology; 2011 Feb; 76(8 Suppl 3):S15-9. PubMed ID: 21339486
[TBL] [Abstract][Full Text] [Related]
56. Pharmacology of the sphingosine-1-phosphate signalling system.
Zu Heringdorf DM; Ihlefeld K; Pfeilschifter J
Handb Exp Pharmacol; 2013; (215):239-53. PubMed ID: 23579459
[TBL] [Abstract][Full Text] [Related]
57. Pulmonary and vascular pharmacology of sphingosine 1-phosphate.
Brinkmann V; Baumruker T
Curr Opin Pharmacol; 2006 Jun; 6(3):244-50. PubMed ID: 16563863
[TBL] [Abstract][Full Text] [Related]
58. Targeting sphingosine 1-phosphate (S1P) levels and S1P receptor functions for therapeutic immune interventions.
Gräler MH
Cell Physiol Biochem; 2010; 26(1):79-86. PubMed ID: 20502007
[TBL] [Abstract][Full Text] [Related]
59. [Therapeutic effect of S1P receptor modifying drugs for autoimmune diseases].
Chiba K; Kataoka H
Nihon Yakurigaku Zasshi; 2008 Mar; 131(3):24-5. PubMed ID: 18421849
[No Abstract] [Full Text] [Related]
60. FTY720: from bench to bedside.
Kahan BD
Transplant Proc; 2004 Mar; 36(2 Suppl):531S-543S. PubMed ID: 15041402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]